Andere talen Attana AB

Aandelen

ATANA

SE0010547273

slotkoers NORDIC GROWTH MARKET Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,076 ^SEK	+1,33%		+16,92%	-23,23%

25/04	Attana AB gaat het derde jaar in van een vijfjarig service- en ondersteuningscontract met een toonaangevend gezondheidsinstituut in de VS	CI
22/02	Attana AB rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Attana enters the third year of a five-year service and support contract with a leading health institute in the US	25/04
Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US	25/04
New paper using Attana tecnology to understand how viruses enter human cells	01/04
One of US leading health institutes has placed an order for an upgrade of an existing instrument, valued at $150k	05/03
Attana AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
New paper using Attana Technology to study structures on surface in Ion Liquids demonstrating the effect of surface charges on interaction properties.	13/02
New publication using Attana technology towards environmentally friendly and financially viable methods to create functional materials	23/01
New article using Attana's technology from National University of Singapore: Immunity differences in vaccinated individuals according to age, gender, lifestyle and other diseases	20/12
Biosensors to characterize immune response to bacterial diseases	18/12
Attana and Linnaeus University have published the first part of the science behind immunity profiles	05/12
Attana Lands Order for Kinetic Interaction Analysis of Tissue in US	04/12
Breakthrough order with new customer in the USA	04/12
Attana AB Receives Breakthrough Order with New Customer in the USA	04/12
Strengthened collaboration with European biotech customer who extends their service and support agreement for another 12 months.	23/11
Customer Develops Therapeutic Antibodies Against Cancer and Uses Attana's Cell-Based Technology	23/11
A new publication using Attana Technology from National University of Singapore examining the neutralization capacity of human IgG antibodies agsinst different mutations of the SARS-CoV-2	20/11
Robust QCM-Based Sensing and Assay Formats in Commercialized Systems	15/11
Attana AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26-10-23
Dear shareholders and valuable followers,	04-10-23
New publication that shows the strength of Attana's offering in diagnostics, here applied in veterinary medicine.	26-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Attana AB

Aandelen

ATANA

SE0010547273

Andere talen

Filters